PTI-808-01: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 inHealthy Adult Subjects and in Adults with Cystic Fibrosis

Project: Research project

Project Details

Description

PTI-808-01: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults with Cystic Fibrosis
StatusActive
Effective start/end date7/1/181/1/21

Funding

  • PROTEOSTASIS THERAPEUTICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.